NetworkNewsBreaks – Trxade Group Inc.’s (NASDA
Post# of 174
(Total Views: 329)
Posted On: 07/20/2020 3:41:20 PM
NetworkNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Corporate Presentation Highlights Milestones, Growing Popularity of Platform
Trxade Group (NASDAQ: MEDS) recently released a corporate presentation that highlights the company’s major milestones, increased revenues and earnings, and the growing popularity of its pharmaceutical platform (http://nnw.fm/O6uf8). An article that discusses the presentation, as well as the company’s achievements as they stand today and since its inception, reads, “Founded in 2010 by MEDS CEO Suren Ajjarapu along with MEDS COO and President Prashant Patel, the Trxade Group spent its first three years working on the technology that would underlie its innovative pharmaceutical platform. Dedicated and passionate, Ajjarapu and Patel bootstrapped early development with some $5.5M of their own funds. Their efforts began to bear fruit in 2013, when the first client came aboard. Not resting on its laurels, the company launched a second service that year — a highly structured single platform — for pharmaceutical distributors to make sourcing supplies easier.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group (NASDAQ: MEDS) recently released a corporate presentation that highlights the company’s major milestones, increased revenues and earnings, and the growing popularity of its pharmaceutical platform (http://nnw.fm/O6uf8). An article that discusses the presentation, as well as the company’s achievements as they stand today and since its inception, reads, “Founded in 2010 by MEDS CEO Suren Ajjarapu along with MEDS COO and President Prashant Patel, the Trxade Group spent its first three years working on the technology that would underlie its innovative pharmaceutical platform. Dedicated and passionate, Ajjarapu and Patel bootstrapped early development with some $5.5M of their own funds. Their efforts began to bear fruit in 2013, when the first client came aboard. Not resting on its laurels, the company launched a second service that year — a highly structured single platform — for pharmaceutical distributors to make sourcing supplies easier.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)